Controlled release (CR), modified release (MR), orally disintegrating tablets (ODT), and other innovative dosage forms are still of interest to both pharmaceutical producers and suppliers. 2014 April, Ken Seufert, “The New Dawn of Pharmaceutical Manufacturing: Innovative Solutions for Unprecedented Challenges”, in American Pharmaceutical Review, 17(3):8: